'Dangerous Drugs' Category
By Simmons Hanly Conroy | December 30, 2013
Generic Drug Competition Shrinks Pfizer’s Profit
Pharmaceutical giant Pfizer had a massive decrease in third-quarter profit due to the increased competition from generic drugs, according to the New York Times. As more generic drugs become available and are… Read More
By Simmons Hanly Conroy | December 26, 2013
Survey Finds OxyContin is Most Abused Prescription Drug
Prescription drugs affect the body in different ways. Opioids, for example are medications used to relieve pain. Also known as painkillers, these include: Codeine Diphenoxylate (Lomotil) Fentanyl (Duragesic) Hydrocodone (Vicodin, Lorcet, Lortab)… Read More
By Simmons Hanly Conroy | December 6, 2013
Study: Cholesterol-Lowering Statins Linked to Cataract Development
Results from a new study found that millions of adults who take popular statin medications to lower their cholesterol may be at increased risk of developing cataracts. Evidence found a link between… Read More
By Simmons Hanly Conroy | November 12, 2013
Help Make Generic Drug Manufacturers Accountable for Safety by Signing Take Justice Back Petition
FDA proposes rule changes to hold generic drug manufacturers accountable for injuries The FDA has proposed new rules that would improve generic drug manufacturer accountability. More than 80 percent of prescriptions are… Read More
By Simmons Hanly Conroy | October 29, 2013
Hawaii Dept. of Health Links Diet Supplement OxyElite Pro to Liver Failure
USPLabs, the manufacturer of the diet supplement called OxyELITE Pro, has halted distribution of the drug nationwide following multiple cases of liver failure linked to the supplement discovered by the Hawaii Department… Read More
By Simmons Hanly Conroy | October 25, 2013
FDA Issues Black Box Warning on Two Cancer Drugs
The hepatitis B warnings on two blood cancer drugs were recently strengthened by the Food and Drug Administration (FDA), according to Fox News. The strengthened warnings were issued to reflect the risk of… Read More
By Simmons Hanly Conroy | September 6, 2013
FDA Strengthens Warning on Lariam, Anti-Malaria Drug
Recently, the Food and Drug Administration (FDA) announced that the commonly used anti-malaria drug, called mefloquine hydrochloride (brand name Lariam) must have a “black box” warning on its label. The drug has… Read More
By Simmons Hanly Conroy | August 29, 2013
Study Links Calcium-Channel Blockers to Breast Cancer
Calcium-channel blockers (CCBs) may be associated with a higher risk of breast cancer, according to a new study. Published in the journal JAMA Internal Medicine, the study looked at the effects of the… Read More
By Simmons Hanly Conroy | July 31, 2013
Roche Halts Development of New Diabetes Drug Due to Safety Concerns
Swiss pharmaceutical giant Roche has stopped further development of its new diabetes drug called aleglitazar. This decision could increase safety concerns for drugs similar to aleglitazar, including the controversial medication called Avandia.… Read More
By Simmons Hanly Conroy | July 29, 2013
Advertising Nets Lipitor Better Sales Despite Dangerous Side Effects, Generic Competition
Pharmaceutical company Pfizer’s lucrative cholesterol drug Lipitor is expected to generate approximately $3 billion in revenue by 2015, according to a recent report by AARP’s Public Policy Institute. The cholesterol medication is… Read More
